Emcure Pharma IPO lists at 31% premium on NSE
Emcure IPO opened on July 3 and closed on July 5. It is a book-built issue valued at ₹1,952.03 crores.
Emcure Pharmaceuticals shares made a strong debut today (July 10) after listing at ₹1,325.05. This marks a premium of 31.5 per cent over the issue price of ₹1,008. The IPO opened on July 3 and closed on July 5. It is a book-built issue valued at ₹1,952.03 crores.

Emcure IPO details
Emcure IPO includes a fresh issue of 0.79 crore shares, aggregating to ₹800 crores. The issue also comprises an offer for sale of 1.14 crore shares, totalling ₹1,152.03 crores. The price band for the IPO was set between ₹960 and ₹1,008 per share and the allotment of shares was finalized on July 8. The IPO is managed by Kotak Mahindra Capital Company Limited, Axis Capital Limited, J.P. Morgan India Private Limited, and Jefferies India Private Limited. The registrar of the IPO is Link Intime India Private Ltd.
Emcure IPO company details
Emcure Pharmaceuticals specialises in the development, manufacturing, and global marketing of pharmaceutical products across various therapeutic areas. Its product portfolio includes orals, injectables, and biotherapeutics and the company operates 13 manufacturing facilities across India.
ABOUT THE AUTHORHT News DeskFollow the latest breaking news, major developments and agenda-setting stories from India and around the world with the newsdesk at Hindustan Times. Operating round the clock, the desk brings together experienced editors, reporters and correspondents to deliver fast, accurate and contextual reporting across subjects that influence public policy, governance, business, society and international affairs. The HT News Desk covers politics, elections, government policies, the economy, business and markets, science and technology, the environment, law and order, infrastructure, education, climate issues and geopolitics, while closely tracking developments across states, institutions and global capitals. The team also leads coverage of major breaking news events, policy announcements, court proceedings, natural disasters, public emergencies and significant international developments. Reports published by the newsdesk are based on information gathered from reporters on the ground, official statements, government agencies, court records, regulatory filings, recognised institutions and other authoritative sources. Stories undergo editorial scrutiny and verification processes to ensure accuracy, fairness and relevance, and are updated as events evolve and additional information becomes available. Whether covering a key political decision in New Delhi, an economic policy shift affecting millions, a landmark court ruling or a major global event, the HT News Desk aims to provide readers with reliable, fact-based journalism that delivers not only the latest developments but also the context and analysis needed to understand their wider implications.Read More

E-Paper


